Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Baruchel

Showing results (261-270 of 590) with videos related to

Pageof 59
Sort By:
European Journal of Radiology|October 3, 2008
The radiotherapy clinical trials projects at the ESRF: technical aspectsM Renier, Th Brochard, C Nemoz, et al.
Haematologica|March 9, 2023
The oncogenetic landscape and clinical impact of <i>BCL11B</i> alterations in adult and pediatric T-cell acute lymphoblastic leukemiaMarie Emilie Dourthe, Guillaume P Andrieu, Amandine Potier, et al.
The Journal of Experimental Medicine|September 22, 2010
NKX3.1 is a direct TAL1 target gene that mediates proliferation of TAL1-expressing human T cell acute lymphoblastic leukemiaSophie Kusy, Bastien Gerby, Nicolas Goardon, et al.
British Journal of Cancer|December 6, 2000
Prognostic study of continuous variables (white blood cell count, peripheral blast cell count, haemoglobin level, platelet count and age) in childhood acute lymphoblastic leukaemia. Analysis Of a population of 1545 children treated by the French Acute Lymphoblastic Leukaemia Group (FRALLE)J Donadieu, M F Auclerc, A Baruchel, et al.
Pediatric Blood & Cancer|August 24, 2013
Head and neck presentations of B-NHL and B-AL in children/adolescents: experience of the LMB89 studyCyril Lervat, Anne Auperin, Catherine Patte, et al.
Pediatric Blood & Cancer|September 17, 2015
A Phase I Study of Clofarabine With Multiagent Chemotherapy in Childhood High Risk Relapse of Acute Lymphoblastic Leukemia (VANDEVOL Study of the French SFCE Acute Leukemia Committee)Brigitte Nelken, Helene Cave, Guy Leverger, et al.
Transfusion|March 30, 2016
Comparison of automated erythrocytapheresis versus manual exchange transfusion to treat cerebral macrovasculopathy in sickle cell anemiaBérengère Koehl, Julie Sommet, Laurent Holvoet, et al.
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|December 31, 2005
Parental decision making in pediatric cancer end-of-life care: using focus group methodology as a prephase to seek participant design inputDeborah Tomlinson, Michael Capra, Janet Gammon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2000
Evaluation of minimal residual disease using reverse-transcription polymerase chain reaction in t(8;21) acute myeloid leukemia: a multicenter study of 51 patientsF Morschhauser, J M Cayuela, S Martini, et al.
Haematologica|December 9, 2008
Effect of transfusion therapy on cerebral vasculopathy in children with sickle-cell anemiaBrigitte Bader-Meunier, Suzanne Verlhac, Monique Elmaleh-Bergès, et al.
Pageof 59

Showing results (261-270 of 590) with videos related to

Sort By:
Pageof 59
European Journal of Radiology|October 3, 2008
The radiotherapy clinical trials projects at the ESRF: technical aspectsM Renier, Th Brochard, C Nemoz, et al.
Haematologica|March 9, 2023
The oncogenetic landscape and clinical impact of <i>BCL11B</i> alterations in adult and pediatric T-cell acute lymphoblastic leukemiaMarie Emilie Dourthe, Guillaume P Andrieu, Amandine Potier, et al.
The Journal of Experimental Medicine|September 22, 2010
NKX3.1 is a direct TAL1 target gene that mediates proliferation of TAL1-expressing human T cell acute lymphoblastic leukemiaSophie Kusy, Bastien Gerby, Nicolas Goardon, et al.
British Journal of Cancer|December 6, 2000
Prognostic study of continuous variables (white blood cell count, peripheral blast cell count, haemoglobin level, platelet count and age) in childhood acute lymphoblastic leukaemia. Analysis Of a population of 1545 children treated by the French Acute Lymphoblastic Leukaemia Group (FRALLE)J Donadieu, M F Auclerc, A Baruchel, et al.
Pediatric Blood & Cancer|August 24, 2013
Head and neck presentations of B-NHL and B-AL in children/adolescents: experience of the LMB89 studyCyril Lervat, Anne Auperin, Catherine Patte, et al.
Pediatric Blood & Cancer|September 17, 2015
A Phase I Study of Clofarabine With Multiagent Chemotherapy in Childhood High Risk Relapse of Acute Lymphoblastic Leukemia (VANDEVOL Study of the French SFCE Acute Leukemia Committee)Brigitte Nelken, Helene Cave, Guy Leverger, et al.
Transfusion|March 30, 2016
Comparison of automated erythrocytapheresis versus manual exchange transfusion to treat cerebral macrovasculopathy in sickle cell anemiaBérengère Koehl, Julie Sommet, Laurent Holvoet, et al.
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|December 31, 2005
Parental decision making in pediatric cancer end-of-life care: using focus group methodology as a prephase to seek participant design inputDeborah Tomlinson, Michael Capra, Janet Gammon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2000
Evaluation of minimal residual disease using reverse-transcription polymerase chain reaction in t(8;21) acute myeloid leukemia: a multicenter study of 51 patientsF Morschhauser, J M Cayuela, S Martini, et al.
Haematologica|December 9, 2008
Effect of transfusion therapy on cerebral vasculopathy in children with sickle-cell anemiaBrigitte Bader-Meunier, Suzanne Verlhac, Monique Elmaleh-Bergès, et al.
Pageof 59